TrialBritish journal of haematology2017

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.

Samer A Srour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.